0.55 (0.03%) Sun Pharmaceutical Industries’ arm Taro Pharmaceutical Industries has hiked prices of couple of its products. The new set of price increases will boost the company’s EBITDA by 4 per cent.
Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.